Managing Myeloma
- 2010-05-11 - Managing Myeloma, Your Primary Professional Myeloma Resource is at the 35th Annual ONS Congress May 13-16: Vist Booth #2023/2025 to Get Your Compendium of Myeloma Treatment Regimens, a First Ever Resource !
- 2010-05-10 - Takeda to Co-Promote bortezomib for Injection in Japan
- 2010-05-10 - News Flash Update:Glaxo Suspends Trial Of Resveratrol Drug-Examining Cast Nephropathy Reports, A Sequelae Common to Myeloma, Some Patients Opting to Continue on Study Drug
- 2010-05-10 - Report: US cost of treating cancer almost doubles over two decades
- 2010-05-09 - Lake Worth Man Taking 90-Day Adventure Westward
- 2010-05-05 - Micromet Gets €5M in Multiple Myeloma Antibody Deal with BI
- 2010-05-05 - AEterna Zentaris: Uncovering The Next Dominant Cancer Company
- 2010-05-04 - NEWS FLASH UPDATE:Glaxo Halts Red Wine Drug Study Enrollment on Safety Concern
- 2010-05-03 - Resveratrol Trial In Multiple Myeloma Suspended Due To Safety Concerns
- 2010-05-03 - CytRx's INNO-206 Rapidly Shrinks Human Tumors in an Animal Model of Multiple Myeloma- Market Watch
- 2010-05-02 - Loveland Man Races For Cancer Research
- 2010-05-02 - Sixteen Years After Diagnosis with Multiple Myeloma, John Ware, former Dallas city manager, dies at 62
- 2010-04-29 - NEWS FLASH/FDA- First-in-Class Active Cellular Immunotherapy for the Treatment of Cancer Approved by the FDA. Sipuleucel-T (Provenge) Approved for certain men with advanced prostate cancer.
- 2010-04-29 - 9th Annual Multiple Myeloma Research Foundation Chicago Awards Dinner Raises $950,000 to Accelerate Development of New Cancer Treatments
- 2010-04-29 - Celgene Q1 2010 Earnings Call Transcript